Chylothorax as an unusual manifestation of transthyretin cardiac amyloidosis: a case report
At this time, we can only speculate about the pathomechanism of chylothorax development in the context of amyloidosis. We recommend further investigation of similar cases to deepen understanding of the underlying causes and identify potential treatment strategies. Additionally, the utility of CA 125 as a prognostic marker in ATTR amyloidosis needs further investigation.
Authors
- Regina Steringer‐Mascherbauer
- Martin Martinek (ORCID: https://orcid.org/0000-0002-8895-8488)
- Christina Pöschl
- Theresa Kratzer
Institutions
- Krankenhaus der Elisabethinen (AT)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/ehjcr/ytae634
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00